Nyrada
Menu
NYR:
Market Cap*:
Price Delay ~20min
Home
About Us
Company Overview
Board of Directors
Management
Scientific Advisory Board
Corporate Governance
Our Science
Lead Drug Development
Brain Injury Program
Cholesterol Lowering Program
Technical Glossary
Drug Development Pathway
Investors
Investor Welcome
ASX Announcements
Brain Injury Program
Cholesterol-Lowering Program
Financial Reports
Corporate Announcements
Investor Presentations
Share Price Information
Key Dates
Investors Glossary
Annual Reports
Analyst Reports
Annual General Meeting
Extraordinary General Meeting
Past Shareholder Meetings
News & Insights
Presentations & Interviews
Media
Newsletters
Publications
Contact Us
Contact Us
Working at Nyrada
Email Alerts
Financial Reports 2023-07-06-13-27
24-Feb-2023
Nyrada Half Year Results FY2023
24-Feb-2023
Appendix 4D and Half Year Report to 31 December 2022
30-Jan-2023
Quarterly Activities Report and Appendix 4C
29-Aug-2022
Preliminary Final Report
26-Oct-2021
Nyrada Quarterly Activities Report & Appendix 4C
30-Aug-2021
Preliminary Final Report
20-Apr-2021
Nyrada Quarterly Activities Report & Appendix 4C
22-Feb-2021
Appendix 4D and Half Year Accounts
28-Jan-2021
Nyrada Quarterly Activities Report & Appendix 4C
13-Oct-2020
Appendix 4C - September 2020 Quarterly Report
31-Aug-2020
FY 2020 Appendix 4E Preliminary Financial Report
22-Jul-2020
Appendix 4C - June 2020 Quarterly Report
22-Jul-2020
Appendix 4C - June 2020 Quarterly Report
14-Apr-2020
Appendix 4C - March 2020 Quarterly Report
25-Feb-2020
Appendix 4D and Half Yearly Accounts
